Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Synapse Formation: Another Piece in Cdk5’s Repertoire?
11 December 2007. In the December 6 Neuron, Li-Huei Tsai and colleagues at MIT report that the kinase Cdk5 controls the distribution of the synapse scaffold protein CASK. The finding strengthens the case that Cdk5, perhaps best known for its role in developmental regulation, also acts in synaptogenesis.

Alzheimer disease researchers are quite familiar with Cdk5, as it promotes both amyloid production (see ARF related news story) and tau phosphorylation (see ARF related news story), two major features of the disease. It has also been linked to degradation of synapses, though not in a kinase-dependent manner (see ARF related news story). The presently reported, new role of Cdk5 in synaptogenesis may pique interest among AD researchers as well, given that loss of synapses may be the best pathological correlate of cognitive decline (see, e.g., DeKosky et al., 1990).

There has been increasing evidence that Cdk5 somehow helps regulate synapses. The kinase phosphorylates several synaptic proteins, including PSD95, and Tsai and colleagues previously demonstrated that transient expression of the Cdk5 activator p25 in mice boosts synapse numbers and improves learning and memory (see ARF related news story). This current paper hints that those cognitive improvements may be related to CASK.

CASK is believed to be a synaptic scaffold protein that supports the architecture necessary for efficient synaptic function. It is recruited to synapses by synaptic proteins SynCam and neurexins/neuroligins. First author Benjamin Samuels and colleagues report that when Cdk5 phosphorylates CASK, this stimulates the association of CASK with membranes, particularly synaptosomes. Expressing a mutant form of CASK that cannot be phosphorylated in cells compromises the cells’ calcium influx.

“CASK represents a novel substrate of Cdk5 that provides a potential mechanism to explain how Cdk5 can drive formation of new synapses,” write the authors. The finding could have implications for studying neurologic diseases. As the authors point out, mutations in neuroligins, which help recruit CASK, have been linked to autism, and CASK has also been linked to parkin, which is mutated in some familial forms of Parkinson disease (see Fallon et al., 2002).—Tom Fagan.

Reference:
Samuels BA, Hsueh Y-P, Shu T, Liang H, Tseng H-C, Hong C-J, Su SC, Volker J, Neve RL, Yue DT, Tsai L-H. Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK. Neuron. 2007 Dec 6;56:823-837. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad